▽NEJM ●05/16 02:19 May 15, 2025Meeting of the American Society of Gene and Cell TherapyBespoke Base Editing for Genetic DiseaseK. Musunuru and OthersA lipid nanoparticle–delivered base-editing therapy was custom designed for an infant with a urea-cycle disorder. The affected infant was treated at approximately 7 and 8 months of age.Editorial Personalized Gene Editing to Treat an Inborn Error of MetabolismEdito